NCT03514290 is a NA clinical trial of Low-lever laser in Tooth Bleaching, sponsored by Universidade Federal do Para.

Who is sponsoring NCT03514290?

NCT03514290 is sponsored by Universidade Federal do Para.

What drugs are being tested in NCT03514290?

Interventions in NCT03514290: Low-lever laser, Tooth bleaching, Placebo.

What condition does NCT03514290 study?

NCT03514290 studies Tooth Bleaching, Low-level Laser Therapy, Dentin Sensitivity, Clinical Trial.

Is NCT03514290 still recruiting?

NCT03514290 is currently completed. Last updated 2 May 2018.

Last reviewed 2018-05-02 · How we verify

NCT03514290

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Low-level Laser Therapy on Post-bleaching Sensitivity and Color Change

Completed NA Last updated 2 May 2018

What this trial tests

NA trial testing Low-lever laser in Tooth Bleaching in 21 participants. Completed in 30 September 2016.

Timeline

11 July 2016

Primary endpoint
8 August 2016

30 September 2016

Quick facts

Lead sponsor	Universidade Federal do Para
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	21
Start date	11 July 2016
Primary completion	8 August 2016
Estimated completion	30 September 2016
Sites	1 location across Brazil

Drugs / interventions tested

Low-lever laser
Tooth bleaching — full drug profile →
Placebo

Conditions studied

Tooth Bleaching — all drugs for Tooth Bleaching →
Low-level Laser Therapy — all drugs for Low-level Laser Therapy →
Dentin Sensitivity — all drugs for Dentin Sensitivity →
Clinical Trial — all drugs for Clinical Trial →

Sponsor

Universidade Federal do Para — full company profile →

Who can join

Adults 18 to 30, any sex, with Tooth Bleaching or Low-level Laser Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: The objective of this clinical study was to evaluate low-level laser (LLL) therapy in tooth sensitivity and in effecting color change after in-officer bleaching treatment across three weeks of treatment. Methods: Twenty-one volunteers were evaluated through the split-mouth model, so that the right and left maxillary/mandibular quadrants were randomized and allocated to one of two groups: GPLACEBO - the laser tip was positioned without the emission of light (placebo effect) + tooth bleaching with 35% hydrogen peroxide (HP); GLASER - treated with LLL + tooth bleaching with 35% HP. To assess tooth sensitivity, a modified visual analogue scale (VAS) was used after an evaporative stimulus (stimulated pain) and a daily pain questionnaire (unstimulated pain) was also applied. A spectrophotometer was used to measure the color. Three bleaching sessions were performed, with intervals of 7 days. Sensitivity results were tested using Friedman test for intra-group evaluation and Wilcoxon test for inter-group evaluation and ANOVA for color change.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Universidade Federal do Para trials

Trials by the same sponsor.

NCT07506850 — Effect of CPP-ACP Associated With NaF or SnF₂ on Post-Bleaching Tooth Sensitivity · NA · completed
NCT06614764 — Effect of Andiroba on Control of Post-whitening Tooth Sensitivity · NA · completed
NCT06872749 — Effect of an Experimental Gel Containing Copaiba Oil-resin in the Control of Dentin Hypersensitivity · NA · completed
NCT06971783 — Effect of an Experimental Gel Based on Acmella Oleracea Extract Associated or Not With Fluoride on Dentin Hypersensitivi · NA · completed
NCT06518629 — Photobiomodulation Before or After Tooth Whitening · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03514290 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidade Federal do Para
Last refreshed: 2 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03514290.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing